Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment

Chagas' disease, a neglected tropical illness for which current therapy is unsatisfactory, is caused by the intracellular parasite Trypanosoma cruzi. The goal of this work is to investigate the in vitro and in vivo effects of the arylimidamide (AIA) DB766 against T. cruzi. This arylimidamide ex...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Batista, Denise da Gama Jaén, Batista, Marcos Meuser, Oliveira, Gabriel Melo de, Amaral, Patrícia Borges do, Lannes-Vieira, Joseli, Britto, Constança Carvalho, Junqueira, Angela, Lima, Marli Maria, Romanha, Alvaro José, Sales Junior, Policarpo Ademar, Stephens, Chad E., Boykin, David W., Soeiro, Maria de Nazaré Correia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2010
Konular:
Experimental Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897275/
https://ncbi.nlm.nih.gov/pubmed/20457822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01617-09
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller